Study Stopped
Low enrollment making completion of the study impossible, relocation of both the PI and Co-PI
Diabetic Fibular Nail Study
Prospective, Randomized-Control Trial Comparing Intramedullary Fibular Fixation With Standard Open Reduction And Internal Fixation In Diabetic Patients With Unstable Ankle Fracture
1 other identifier
interventional
2
1 country
1
Brief Summary
Our null hypothesis is that fibular intramedullary fixation (IMFN) does not impact complication rates when compared to standard of care treatment with open reduction and internal fixation (ORIF). There are no current or past RCTs comparing these fixation techniques to one another in diabetic patients. There is good data supporting both the use of intramedullary fixation for fibular fractures alone, and in high-risk patient populations (elderly, and diabetics). However, the effectiveness of these methods with respect to each other has never been investigated. The knowledge gained will allow us to potentially influence and adapt protocols to treat this patient population. Additionally, resources available at our institution provide a supportive framework with which to maintain contact with patients after hospital discharge. These key factors will allow us to perform a robust analysis of this population, to include outcomes measures of function and complications.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 12, 2022
CompletedFirst Posted
Study publicly available on registry
January 24, 2022
CompletedStudy Start
First participant enrolled
March 7, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 19, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 19, 2024
CompletedOctober 16, 2024
October 1, 2024
1.9 years
January 12, 2022
October 11, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Composite complication rate
The difference in overall composite complication rate between Fibular intramedullary fixation and ORIF
1 year post-operatively
Secondary Outcomes (1)
Patient reported outcome scores
1 year post-operatively
Study Arms (2)
Fibular intramedullary nail
ACTIVE COMPARATORRandomized in the OR to ankle fracture repair with fibular intramedullary nail
Open reduction and internal fixation (ORIF)
ACTIVE COMPARATORRandomized in the OR to ankle fracture repair with ORIF
Interventions
The standard manufacturers approved technique will be performed including the use of 2 distal interlocking screws and the use of a minimum of 1 fibula pro tibia fixation screw depending on the patients' anatomical characteristics.
An open approach (direct lateral or posterolateral incision) will be carried out. The reduction will be performed using standard techniques of clamping and traction. Fixation will be performed after reduction of the fracture with a plate and screw construct. The surgeon will then proceed to perform surgical fixation of other associated fractures or ligament injuries as indicated. This will most often include open reduction and internal fixation of the medial malleolus with screws through a separate medial incision.
Eligibility Criteria
You may qualify if:
- Age 18 or older
- Unstable ankle fracture
- Diagnosis of Diabetes:
- Fasting BG \> 120
- Non-fasting BG \> 200
- HbA1c \> 6.5
You may not qualify if:
- Poly-trauma patients (multiple \[\>2\] extremity injuries that interfere and/or limit patient mobilization
- Open fractures
- Delayed presentation of fracture (\>4 weeks)
- Fractures that the treating surgeon indicates requires a posterior approach to achieve stability
- Patients with an active infection or wound at the ankle
- Utilizing worker's compensation at the time of screening
- Any previous ligament or fracture surgery on the index ankle
- Inflammatory rheumatic disease or other rheumatic disease
- Immune compromised patients (hepatitis, HIV, etc.)
- Non-English speaking patients
- Unwilling or unable to follow study protocol
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Chicago
Chicago, Illinois, 60637, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kelly Hynes, MD
University of Chicago
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 12, 2022
First Posted
January 24, 2022
Study Start
March 7, 2022
Primary Completion
January 19, 2024
Study Completion
January 19, 2024
Last Updated
October 16, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share
IPD will not be shared with other researchers.